The US Food and Drug Administration will move into the process of drafting an implementable Quality Management Maturity rating system after a 2 November public endorsement of the concept from its Pharmaceutical Science & Clinical Pharmacology Advisory Committee.
The committee review amounted to the final stop on FDA’s process to build support at the conceptual level for the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?